These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 30964364

  • 21. Health-related quality of life and its determinants among patients with diabetes mellitus: a multicentre cross-sectional study in Northwest Ethiopia.
    Sendekie AK, Dagnew EM, Tefera BB, Belachew EA.
    BMJ Open; 2023 Jan 25; 13(1):e068518. PubMed ID: 36697040
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
    Zare F, Ameri H, Madadizadeh F, Aghaei MR.
    Diabetes Metab Syndr; 2021 Jan 25; 15(1):319-324. PubMed ID: 33486224
    [Abstract] [Full Text] [Related]

  • 25. Health-related quality of life and caregiver burden of pediatric patients with inborn errors of metabolism in Japan using EQ-5D-Y, PedsQL, and J-ZBI.
    Konomura K, Numakura C, Nakamura-Utsunomiya A, Hoshino E, Tajima G, Kobayashi H, Nakamura K, Shimozawa N, Bo R, Shiroiwa T, Shigematsu Y, Fukuda T.
    Qual Life Res; 2024 Dec 25; 33(12):3323-3333. PubMed ID: 39230839
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Measurement properties of the EQ-5D-Y-3L, PedsQL 4.0, and PROMIS-25 Profile v2.0 in pediatric patients with spinal muscular atrophy.
    Xu RH, Zhao Z, Mao Z, Wang S, Xiong H, Dong D.
    Health Qual Life Outcomes; 2024 Jun 27; 22(1):50. PubMed ID: 38937825
    [Abstract] [Full Text] [Related]

  • 29. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS, Purba FD, Stolk E, Busschbach JJV.
    Health Qual Life Outcomes; 2022 Jun 03; 20(1):88. PubMed ID: 35659313
    [Abstract] [Full Text] [Related]

  • 30. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
    Åström M, Persson C, Lindén-Boström M, Rolfson O, Burström K.
    Qual Life Res; 2018 Nov 03; 27(11):2859-2871. PubMed ID: 30196340
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Health-related quality of life (HRQOL) and its associated factors in children with Type 1 Diabetes Mellitus (T1DM).
    Murillo M, Bel J, Pérez J, Corripio R, Carreras G, Herrero X, Mengibar JM, Rodriguez-Arjona D, Ravens-Sieberer U, Raat H, Rajmil L.
    BMC Pediatr; 2017 Jan 13; 17(1):16. PubMed ID: 28086765
    [Abstract] [Full Text] [Related]

  • 33. Measuring health-related quality of life in children with suspected genetic conditions: validation of the PedsQL proxy-report versions.
    Smith HS, Leo M, Goddard K, Muessig K, Angelo F, Knight S, Outram S, Kelly NR, Rini C.
    Qual Life Res; 2024 Jun 13; 33(6):1541-1553. PubMed ID: 38472717
    [Abstract] [Full Text] [Related]

  • 34. Feasibility of Proxy-Reported EQ-5D-3L-Y and Its Agreement in Self-reported EQ-5D-3L-Y for Patients With Adolescent Idiopathic Scoliosis.
    Lin J, Wong CKH, Cheung PWH, Luo N, Cheung JPY.
    Spine (Phila Pa 1976); 2020 Jul 01; 45(13):E799-E807. PubMed ID: 32539293
    [Abstract] [Full Text] [Related]

  • 35. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM, Knake S, Rosenow F, Reese JP, Conradi N, Strzelczyk A.
    Epilepsy Behav; 2022 Feb 01; 127():108554. PubMed ID: 35063789
    [Abstract] [Full Text] [Related]

  • 36. Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results.
    Otto C, Barthel D, Klasen F, Nolte S, Rose M, Meyrose AK, Klein M, Thyen U, Ravens-Sieberer U.
    Qual Life Res; 2018 Apr 01; 27(4):879-890. PubMed ID: 29189988
    [Abstract] [Full Text] [Related]

  • 37. Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.
    Lecumberri E, Ortega M, Iturregui M, Quesada JA, Vázquez C, Orozco D.
    Curr Med Res Opin; 2018 Jun 01; 34(6):1053-1059. PubMed ID: 29300101
    [Abstract] [Full Text] [Related]

  • 38. Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L.
    N'Goran AA, Déruaz-Luyet A, Haller DM, Zeller A, Rosemann T, Streit S, Herzig L.
    PLoS One; 2017 Jun 01; 12(12):e0188499. PubMed ID: 29261695
    [Abstract] [Full Text] [Related]

  • 39. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH, Zhu L, Sun R, Tan RL, Luo N, Zou S, Dong D.
    Eur J Pediatr; 2022 Dec 01; 181(12):4049-4058. PubMed ID: 36156120
    [Abstract] [Full Text] [Related]

  • 40. Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus.
    Tamási B, Brodszky V, Péntek M, Gulácsi L, Hajdu K, Sárdy M, Szegedi A, Bata-Csörgő Z, Kinyó Á, Rencz F.
    Br J Dermatol; 2019 Apr 01; 180(4):802-809. PubMed ID: 29897626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.